Colonial Trust’s Avanos Medical AVNS Stock Holding History

Colonial Trust’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-12	Closed	-$299	–	1147
2026 Q2	$299	Hold	12	–	–	﹤0.01%	1114
2026 Q1	$168	Hold	12	–	–	﹤0.01%	1128
2025 Q4	$135	Hold	12	–	–	﹤0.01%	1086
2025 Q3	$139	Hold	12	–	–	﹤0.01%	1083
2025 Q2	$147	Hold	12	–	–	﹤0.01%	1084
2025 Q1	$172	Hold	12	–	–	﹤0.01%	1080
2024 Q4	$191	Hold	12	–	–	﹤0.01%	1310
2024 Q3	$288	Hold	12	–	–	﹤0.01%	1092
2024 Q2	$239	Buy	+12	New	+$234	﹤0.01%	978

Other funds holding AVNS

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Colonial Trust's AVNS Position: Q3 2026 in Review

Colonial Trust sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 12 shares — an estimated $299 sold.

Colonial Trust first reported a position in AVNS in Q2 2024 and held it in 9 quarters. The position peaked at $299 in Q2 2026. 2 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

Colonial Trust reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
Colonial Trust sold 12 Avanos Medical shares in Q3 2026, an estimated $299.
Colonial Trust first reported a position in Avanos Medical in Q2 2024 and held it in 9 quarters.
Colonial Trust's Avanos Medical position peaked at $299 in Q2 2026.
2 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Colonial Trust's 13F filing for Q3 2026, filed 10 Nov 2026.